These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22316577)

  • 1. Questions raised by the failure of a trial of short-term psychodynamic therapy versus pharmacotherapy for major depressive disorder.
    Kocsis JH
    J Clin Psychiatry; 2012 Jan; 73(1):64-5. PubMed ID: 22316577
    [No Abstract]   [Full Text] [Related]  

  • 2. Journal Watch review of Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
    Jain S
    J Am Psychoanal Assoc; 2014 Feb; 62(1):113-5. PubMed ID: 24610762
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for short-term psychodynamic psychotherapy for depression.
    Abbass AA; Shedler J; Town JM
    J Clin Psychiatry; 2012 May; 73(5):718; author reply 718-20. PubMed ID: 22697196
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure rate and "professional subjects" in clinical trials of major depressive disorder.
    Shiovitz TM; Zarrow ME; Shiovitz AM; Bystritsky AM
    J Clin Psychiatry; 2011 Sep; 72(9):1284; author reply 1284-5. PubMed ID: 21951988
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
    Barber JP; Barrett MS; Gallop R; Rynn MA; Rickels K
    J Clin Psychiatry; 2012 Jan; 73(1):66-73. PubMed ID: 22152401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining antidepressant medications: a good idea?
    Rush AJ
    Am J Psychiatry; 2010 Mar; 167(3):241-3. PubMed ID: 20194484
    [No Abstract]   [Full Text] [Related]  

  • 8. Sertraline versus venlafaxine XR in major depressive disorder.
    Lusicic A; Jagadheesan K
    J Clin Psychiatry; 2007 Oct; 68(10):1618-9; author reply 1619. PubMed ID: 17960983
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinically Useful Genetic Markers of Antidepressant Response: How Do We Get There From Here?
    McMahon FJ
    Am J Psychiatry; 2015 Aug; 172(8):697-9. PubMed ID: 26234589
    [No Abstract]   [Full Text] [Related]  

  • 10. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
    Schatzberg AF; DeBattista C; Lazzeroni LC; Etkin A; Murphy GM; Williams LM
    Am J Psychiatry; 2015 Aug; 172(8):751-9. PubMed ID: 25815420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flat dose-response curves for efficacy: what do they mean to the clinician?
    Preskorn SH
    J Psychiatr Pract; 2008 Jul; 14(4):232-6. PubMed ID: 18664892
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
    Arnow BA; Blasey C; Williams LM; Palmer DM; Rekshan W; Schatzberg AF; Etkin A; Kulkarni J; Luther JF; Rush AJ
    Am J Psychiatry; 2015 Aug; 172(8):743-50. PubMed ID: 25815419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant switching among adherent patients treated for depression.
    Marcus SC; Hassan M; Olfson M
    Psychiatr Serv; 2009 May; 60(5):617-23. PubMed ID: 19411348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antidepressants for older people: a critical review of the evidence base.
    Katona C
    Encephale; 2008 Apr; 34 Suppl 2():S71-S76. PubMed ID: 18675006
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful use of agomelatine and venlafaxine combination in major depression.
    Dahale AB; Narayanaswamy JC; Venkatasubramanian G; Bagewadi VI
    Gen Hosp Psychiatry; 2014; 36(1):e3. PubMed ID: 24120022
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient preference compared with random allocation in short-term psychodynamic supportive psychotherapy with indicated addition of pharmacotherapy for depression.
    Van HL; Dekker J; Koelen J; Kool S; van Aalst G; Hendriksen M; Peen J; Schoevers R
    Psychother Res; 2009 Mar; 19(2):205-12. PubMed ID: 19396651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAR*D: what have we learned?
    Rush AJ
    Am J Psychiatry; 2007 Feb; 164(2):201-4. PubMed ID: 17267779
    [No Abstract]   [Full Text] [Related]  

  • 18. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.
    Eckert L; Lançon C
    BMC Psychiatry; 2006 Jul; 6():30. PubMed ID: 16867188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.